# Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention

Study · id `cardio:ct-nct01442792` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01442792](<https://clinicaltrials.gov/study/NCT01442792>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01442792

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.

## Technical summary

Registry record NCT01442792. Randomized; no masking; primary purpose prevention. Start 2011-10-12 (actual); primary completion 2013-01-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 108 participants (enrolled count; ClinicalTrials.gov record NCT01442792, source copy `cardio:ctgov-nct01442792-2022-06-23`, retrieved 2026-10-26)
- Started: 2011-10-12 (actual) (ClinicalTrials.gov record NCT01442792, source copy `cardio:ctgov-nct01442792-2022-06-23`, retrieved 2026-10-26)
- Primary completion: 2013-01-29 (actual) (ClinicalTrials.gov record NCT01442792, source copy `cardio:ctgov-nct01442792-2022-06-23`, retrieved 2026-10-26)
- Completion: 2013-03-04 (actual) (ClinicalTrials.gov record NCT01442792, source copy `cardio:ctgov-nct01442792-2022-06-23`, retrieved 2026-10-26)
- Countries: Belgium; Netherlands (ClinicalTrials.gov record NCT01442792, source copy `cardio:ctgov-nct01442792-2022-06-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01442792-2022-06-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention
- Acronym: X-PLORER
- Condition: Cardiovascular Disease
- Condition: Coronary Artery Disease
- Intervention (Drug): UFH
- Intervention (Drug): Rivaroxaban (Xarelto, BAY59-7939)
- Intervention (Drug): Rivaroxaban (Xarelto, BAY59-7939)
- Intervention (Drug): Rivaroxaban (Xarelto, BAY59-7939) and UFH
- Lead sponsor: Bayer
- Lead sponsor class: INDUSTRY
- Collaborator: Janssen Research & Development, LLC
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Bayer (`cardio:bayer`)
- Registry lists this organization as a collaborator: Janssen Research & Development, LLC (`cardio:org-janssen-research-development-llc`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease. The X-PLORER trial (`cardio:pubmed-25925992`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 32508c09228e41b632ecc6241642b9caaaf83053b27942e34c7b879f9d1bf38a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
